SBIR/STTR Opportunity: Patterned, Responsive Cellular Therapies Using Novel Mammalian Cellular Regulator Systems
The Defense Advanced Research Projects Agency (DARPA) Small Business Programs Office (SBPO) is issuing an SBIR/STTR Opportunity (SBO) inviting submissions of innovative research concepts in the technical domain of Biomedical Technology. In particular, DARPA is interested in understanding the feasibility of Patterned, Responsive Cellular Therapies Using Novel Mammalian Cellular Regulator Systems.This SBO is issued under the Broad Agency Announcement (BAA) for SBIR/STTR, HR001119S0035. All proposals in response to the technical area(s) described herein will be submitted in accordance with the instructions provided under HR001119S0035, found here: https://www.fbo.gov/spg/ODA/DARPA/CMO/HR001119S0035/listing.htmlThis SBO will open for proposals on September 27, 2019 and close on October 28, 2019.
BAA Coordinator
HR001119S0035@darpa.mil
